Xarelto [summary of product characteristics]. Berlin, Germany: Bayer Pharma AG; May 2012.
EINSTEIN Investigators. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010;363(26):2499-2510.
EINSTEIN Investigators. Oral rivaroxaban for symptomatic venous thromboembolism. Supplementary appendix. N Engl J Med.